Latest Drug Coverage news from across the web.
Though 47% of respondents point the finger at corporate health insurers, respondents also selected the federal government (36%) and drug companies (34%) as primary drivers in rising costs.
Read full article →The Centers for Medicare and Medicaid Services (CMS) aims to play a bigger role in health tech modernization efforts, including leading interoperability initiatives.
Read full article →Yale New Haven Health System is deploying Rad AI solutions across its imaging network, spanning more than 16 outpatient imaging centers and five hospital campuses.
Read full article →At Gastro Health, executives report a 24% reduction in live agent handle time since implementing the solution.
Read full article →What rising expectations from health plans reveal about the next era of payment integrity leadership.
Read full article →InStride Health, a provider of specialty mental healthcare to children, teens and young adults, landed $30 million in series C funding to fuel its growth as it expands to new markets and broadens its network of payer partners.
Read full article →How RxSense helped a health system invest in its own PBM and take control of rising GLP-1 costs.
Read full article →In healthcare, building trust in AI is successful when roles are clear and limits are honest. Here's what that looks like in medical transportation.
Read full article →But inside the health department, workers say the dysfunction of the DOGE era persists.
Read full article →The Trump administration is floating a proposal to establish a permanent framework for the Medicare drug price negotiations, as enabled by the Inflation Reduction Act (IRA).
Read full article →The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court docs suggest the agency has reached an agreement with Optum Rx.
Read full article →Chip giant Nvidia is working with startup Abridge to train a healthcare-specific artificial intelligence foundation model tailored to clinical conversations.
Read full article →